The polycystic kidney disease drug pipeline is advancing with novel therapies targeting cyst growth, inflammation, and gene modulation to slow disease progression and improve patient outcomes. https://www.expertmarketresearch.com/clinical-trials/polycystic-kidney-disease-drug-pipeline-analysis